TELA Relative Valuation
TELA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TELA is overvalued; if below, it's undervalued.
Historical Valuation
TELA Bio Inc (TELA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.43. The fair price of TELA Bio Inc (TELA) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：1.13
Fair
-1.82
PE
1Y
3Y
5Y
Trailing
Forward
-3.05
EV/EBITDA
TELA Bio Inc. (TELA) has a current EV/EBITDA of -3.05. The 5-year average EV/EBITDA is -5.48. The thresholds are as follows: Strongly Undervalued below -9.89, Undervalued between -9.89 and -7.68, Fairly Valued between -3.28 and -7.68, Overvalued between -3.28 and -1.07, and Strongly Overvalued above -1.07. The current Forward EV/EBITDA of -3.05 falls within the Overvalued range.
-2.26
EV/EBIT
TELA Bio Inc. (TELA) has a current EV/EBIT of -2.26. The 5-year average EV/EBIT is -4.30. The thresholds are as follows: Strongly Undervalued below -7.11, Undervalued between -7.11 and -5.71, Fairly Valued between -2.89 and -5.71, Overvalued between -2.89 and -1.48, and Strongly Overvalued above -1.48. The current Forward EV/EBIT of -2.26 falls within the Overvalued range.
0.57
PS
TELA Bio Inc. (TELA) has a current PS of 0.57. The 5-year average PS is 3.00. The thresholds are as follows: Strongly Undervalued below -0.99, Undervalued between -0.99 and 1.01, Fairly Valued between 4.99 and 1.01, Overvalued between 4.99 and 6.98, and Strongly Overvalued above 6.98. The current Forward PS of 0.57 falls within the Undervalued range.
0.00
P/OCF
TELA Bio Inc. (TELA) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.42. The thresholds are as follows: Strongly Undervalued below -18.89, Undervalued between -18.89 and -9.65, Fairly Valued between 8.82 and -9.65, Overvalued between 8.82 and 18.05, and Strongly Overvalued above 18.05. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
TELA Bio Inc. (TELA) has a current P/FCF of 0.00. The 5-year average P/FCF is -5.66. The thresholds are as follows: Strongly Undervalued below -58.71, Undervalued between -58.71 and -32.19, Fairly Valued between 20.86 and -32.19, Overvalued between 20.86 and 47.38, and Strongly Overvalued above 47.38. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
TELA Bio Inc (TELA) has a current Price-to-Book (P/B) ratio of 29.80. Compared to its 3-year average P/B ratio of 13.97 , the current P/B ratio is approximately 113.36% higher. Relative to its 5-year average P/B ratio of 6.76, the current P/B ratio is about 340.67% higher. TELA Bio Inc (TELA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -38.44%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -30.49% , the current FCF yield is about -100.00% lower.
29.54
P/B
Median3y
13.97
Median5y
6.76
-62.58
FCF Yield
Median3y
-38.44
Median5y
-30.49
Competitors Valuation Multiple
The average P/S ratio for TELA's competitors is 0.00, providing a benchmark for relative valuation. TELA Bio Inc Corp (TELA) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 9.14%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of TELA decreased by 62.25% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 18.96M to 20.69M.
The secondary factor is the Margin Expansion, contributed -24.00%to the performance.
Overall, the performance of TELA in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is TELA Bio Inc (TELA) currently overvalued or undervalued?
What is TELA Bio Inc (TELA) fair value?
How does TELA's valuation metrics compare to the industry average?
What is the current P/B ratio for TELA Bio Inc (TELA) as of Dec 05 2025?
What is the current FCF Yield for TELA Bio Inc (TELA) as of Dec 05 2025?
What is the current Forward P/E ratio for TELA Bio Inc (TELA) as of Dec 05 2025?